← Browse by Condition
Medical Condition

cognition

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for cognition sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cognition Clinical Trials

How many clinical trials are currently recruiting for cognition?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for cognition, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cognition?
cognition research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cognition clinical trial?
Eligibility criteria for cognition trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
Rousselot BVBA 2 trials
University Hospital, Grenoble 1 trial
University of Minnesota 1 trial
Fundacion Miguel Servet 1 trial
Georgia State University 1 trial

Recruiting Clinical Trials

NCT04182087
Recruiting
Cognitive Function Assessment in Patients With Focal Brain Injury
Enrollment
400 pts
Location
France
Sponsor
University Hospital, Grenoble
View Trial →
NCT07388043
Recruiting
A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Performance at Varying Dosages in Healthy Middle-aged and Older Adults With Self-reported Memory Problems
Enrollment
120 pts
Location
Canada
Sponsor
Rousselot BVBA
View Trial →
NCT07263022 Phase 3
Recruiting
Cognitive Strategies in Early Psychosis 2
Enrollment
24 pts
Location
United States
Sponsor
University of Minnesota
View Trial →
NCT06677359
Recruiting
Impact of Creatine Monohydrate Micronized Supplementation With or Without Multicomponent Training in Older Adults.
Enrollment
120 pts
Location
Spain
Sponsor
Fundacion Miguel Servet
View Trial →
NCT07388576
Recruiting
A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Function at Varying Dosages in Healthy Younger Adults With Self-reported Attention Problems
Enrollment
120 pts
Location
Canada
Sponsor
Rousselot BVBA
View Trial →
NCT06867198
Recruiting
Peanuts for Cardiometabolic, Brain, and Intestinal Health
Enrollment
72 pts
Location
United States
Sponsor
Georgia State University
View Trial →
NCT06810570
Recruiting
The Effect of Mobile Devices on the Development and Health of Young Children
Enrollment
874 pts
Location
United Kingdom
Sponsor
Sheffield Hallam University
View Trial →
NCT05132517
Recruiting
Magnesium and Cognition After Stroke
Enrollment
80 pts
Location
Germany
Sponsor
BDH-Klinik Hessisch Oldendorf
View Trial →

Related Conditions

focal brain injury (1) cognitive performance (1) psychosis (1) schizophrenia disorder (1) schizoaffective disorder (1) major depressive disorder with psychotic features (1) bipolar disorder with psychotic features (1) psychosis nos (1) schizophreniform disorder (1) psychotic disorder (1) functionality (1) strength training effects (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology